More than half of young children identified as living with someone who has an active hepatitis B infection had a potentially infectious household contact other than their birth mother, according to new research that raises questions about revised US newborn vaccination guidance.
The findings, presented at IDWeek 2026 and highlighted in an October 21 research announcement, showed that 58.2% of children with an identified household exposure opportunity had a contact other than their mother who carried the virus.
The results add evidence to concerns about federal hepatitis B vaccination recommendations adopted in December 2025, which allow parents and clinicians to decide whether to administer a birth dose when the mother tests negative for the virus.
The research, also covered by Reuters on October 23, identifies potential exposure pathways rather than confirmed infections. It does not establish that the federal policy change has caused additional cases of hepatitis B among infants.
What the New Hepatitis B Study Found
Researchers from Kaiser Permanente Northern California examined approximately 158,000 children younger than five living in roughly 131,000 households. The household population was identified using records associated with June 16, 2023.
They found 2,024 children living with at least one household member who had an active hepatitis B virus infection, representing approximately 1.3% of the children studied.
Among those 2,024 children:
- 1,178 children (58.2%) had an identified potentially infectious household contact other than their birth mother.
- 846 children (41.8%) had a birth mother identified as a household contact with hepatitis B.
All children in the maternal-infection group had received hepatitis B vaccination within seven days of birth, compared with 93.5% of children in the nonmaternal household-contact group, according to the investigators.
The researchers argue that screening pregnant women for hepatitis B, while essential, cannot identify every infected person an infant may encounter after birth.
Karen B. Jacobson, an infectious disease physician and researcher involved in the study, emphasized that potential exposure is not limited to an infected mother. The findings were published in an October 21 Kaiser Permanente research report.
Importantly, the 58.2% figure applies only to the children with identified household exposure opportunities. It does not mean that 58.2% of American newborns live with an infected person or that the children in this group contracted hepatitis B.
How US Newborn Hepatitis B Guidance Changed
On December 16, 2025, the Centers for Disease Control and Prevention adopted a recommendation allowing shared clinical decision-making about the hepatitis B birth dose for infants whose mothers test negative for the virus.
The decision replaced the previous routine universal birth-dose recommendation with a more individualized approach for that group of infants.
Under the CDC's December 2025 guidance, parents and healthcare professionals may decide together whether to vaccinate at birth or begin the series later. When the birth dose is deferred, the CDC suggests beginning the series no earlier than two months of age.
The change does not eliminate newborn hepatitis B vaccination. Infants whose mothers test positive for hepatitis B, or whose infection status is unknown, are still recommended to receive the vaccine within 12 hours of birth. Additional hepatitis B immune globulin protection applies according to the relevant clinical guidance.
The CDC explained that the decision reflected confidence in prenatal screening and the low incidence of mother-to-child transmission under existing US prevention practices. Its guidance also explicitly identifies an infected household member as a risk factor that should be considered during shared decision-making.
The American Academy of Pediatrics, however, continues to recommend hepatitis B vaccination within the first 24 hours of life, as outlined in its hepatitis B vaccine guidance.
NewsFusion365 previously reported on the CDC's December 2025 hepatitis B recommendation change. The newly presented research adds information about potential household exposure that is relevant to the debate over vaccination timing.
Why Household Exposure Matters
Hepatitis B is a viral infection affecting the liver. It can spread through contact with infected blood and certain other body fluids, including transmission from mother to child during childbirth.
Household transmission can also occur when infected blood reaches another person's bloodstream through broken skin or mucous membranes. Sharing items that may contain traces of blood, such as toothbrushes or razors, can create exposure opportunities.
Ordinary activities such as hugging, sharing meals or casual contact do not transmit hepatitis B.
The concern raised by the new research is that an infant may live with an infected relative or another household member even when the birth mother has tested negative.
This distinction matters because infection acquired very early in life is particularly likely to become chronic. According to the IDWeek research announcement, approximately 90% of infants who acquire hepatitis B develop chronic infection, which can lead to serious complications, including cirrhosis and liver cancer.
That percentage describes the risk of chronic infection after an infant becomes infected. It is not the probability that a child sharing a household with someone who has hepatitis B will contract the virus.
What the Research Cannot Yet Establish
The study offers evidence about where potential household exposure may arise, but several limitations are important.
First, identifying a child who shares a household with someone who has active hepatitis B does not demonstrate that transmission occurred. The researchers did not establish that the 2,024 children had become infected through those contacts.
Second, the findings come from an observational analysis of one Northern California healthcare population. Household composition, vaccination patterns and infection prevalence may differ elsewhere in the United States.
Third, although the findings were presented at IDWeek 2026, a peer-reviewed journal publication of this specific analysis has not been independently verified. Conference findings can provide useful evidence but should not automatically be treated as equivalent to a fully published and independently scrutinized study.
Finally, the household cohort was identified before the December 2025 federal recommendation change. The analysis therefore cannot directly measure whether that policy has led to additional infant hepatitis B infections.
Determining that would require appropriate follow-up evidence examining infection outcomes and vaccination patterns after the guidance changed, with careful attention to other factors that might influence the results.
What Comes Next for Newborn Vaccination Policy
The findings highlight an important question for public-health authorities: how reliably can vaccination decisions based on maternal screening and individual risk assessment account for infected household members who may not be identified?
Researchers supporting universal newborn vaccination argue that a routine birth dose offers protection before all possible household exposures are known. The CDC's revised approach places greater emphasis on discussions between clinicians and families when maternal hepatitis B testing is negative.
The next evidence needed includes peer-reviewed publication of the household-exposure analysis, broader studies involving different populations and reliable monitoring of hepatitis B infections and vaccination coverage following the policy change.
For families, the distinction between federal guidance and professional pediatric recommendations remains relevant. Decisions about an individual newborn's vaccination schedule should be made with a qualified healthcare professional who can consider maternal testing, household risk factors and applicable clinical guidance.
The October 2026 findings do not prove that changing the birth-dose recommendation has increased infections. They do, however, demonstrate why examining exposure beyond the birth mother matters when assessing how newborn hepatitis B prevention policies protect children.
0 Comments